Entheon Biomedical Corp. (ENBI.CN)
Entheon Biomedical Corp. operates in the Biotechnology industry of the Healthcare sector, headquartered in Vancouver, BC, CA. The stock last traded at $0.10, up 0.00% on the session, giving a market capitalisation of $1.4M. Its beta of 1.59 implies it has historically moved more than the broad market.
Entheon Biomedical Corp. functions as a biotechnology firm focused on the research and development of novel pharmaceuticals. The company is actively involved in pioneering and introducing to market psychedelic therapeutic products, specifically those derived from N,N-dimethyltryptamine (DMT), with the aim of combating addiction and various substance use disorders. Its services are provided to medical doctors, healthcare facilities, and accredited psychiatrists across Canada, the United States, and the European Union. Entheon Biomedical Corp.'s primary operations are based in Vancouver, Canada.
Entheon Biomedical Corp. is most often compared with the following Healthcare names: